Hester Biosciences Operational Benchmarking
₹2,057.20-5.08%close, 9 Oct 2026
- Market cap
- ₹1,750 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,481.18 – ₹2,777.22
Hester Biosciences compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Hester Biosciences sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Hester Biosciences Limited | ₹2,057.20 | 22.5 | 1,750 | 1.2% | 438 | 14.5% |
| Median (1 Cos) | ₹2,057.20 | 22.5 | 1,750 | 1.2% | 438 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
Trade Hester Biosciences With ATS
Track HESTERBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.